Treatment for glioblastoma (GBM)
This site is intended for US healthcare professionals only.


In this section, you'll find a variety of resources to help you better understand Optune, share this novel treatment with your newly diagnosed and recurrent glioblastoma (GBM) patients, and start prescribing Optune.

EF-14 5-Year Survival Results

Review the data from the EF-14 clinical trial.
Download now

Peer-to-Peer Education

A peer-to-peer educational program where you can learn more about Optune from a Novocure trained speaker.
Speak to a peer

Navigating Your Neuro-Oncology Patients

An educational program developed in conjunction with AONN+ to help you navigate your neuro-oncology patients.
View Webinar

Peer-reviewed publications

Review various publications about Optune.
See publications

Patient educational materials

Helpful materials to introduce Optune to your patients.
Get resources

Video library

Materials to help you become more familiar with Optune.
Watch videos

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).